Sterling
Executive Summary
Firm's OTC and Rx products will be marketed and manufactured in Korea under joint venture with South Korean firm Heung-II Pharmaceutical, Sterling announced Aug. 22. The venture, to be known as Sterling Drug Korea Ltd., will also produce and market Heung-II's vitamin and OTC lines.